SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

MetaVia Reports Preclinical DA-1726 Weight-Loss Data

MetaVia said preclinical results showed DA-1726 achieved weight loss comparable to retatrutide with less food-intake suppression.

MTVA

Related stories